|
MLL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.120640E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.601900E-02 |
| Normal-vs-Stage2 |
2.103800E-03 |
| Normal-vs-Stage3 |
8.041500E-04 |
| Normal-vs-Stage4 |
6.081100E-03 |
| Stage1-vs-Stage2 |
6.046100E-02 |
| Stage1-vs-Stage3 |
6.206300E-02 |
| Stage1-vs-Stage4 |
2.360600E-01 |
| Stage2-vs-Stage3 |
6.280800E-01 |
| Stage2-vs-Stage4 |
5.712200E-01 |
| Stage3-vs-Stage4 |
8.402600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.584800E-03 |
| Normal-vs-AfricanAmerican |
3.516300E-02 |
| Normal-vs-Asian |
3.652600E-01 |
| Caucasian-vs-AfricanAmerican |
9.222800E-01 |
| Caucasian-vs-Asian |
7.190300E-02 |
| AfricanAmerican-vs-Asian |
1.650970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.214450E-02 |
| Normal-vs-Female |
1.263420E-03 |
| Male-vs-Female |
8.402400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.134500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.450240E-02 |
| Normal-vs-Age(61-80Yrs) |
7.9037000000004E-05 |
| Normal-vs-Age(81-100Yrs) |
6.377400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.222400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.940400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.259350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.381600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.029200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.036200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.420000E-04 |
| Classical-VS-Follicular |
8.162600E-04 |
| Classical-VS-Other |
9.185400E-01 |
| Classical-VS-Normal |
8.847700E-02 |
| Tall-VS-Follicular |
5.918000E-01 |
| Tall-VS-Other |
2.859400E-01 |
| Tall-VS-Normal |
9.56599999999419E-05 |
| Follicular-VS-Other |
2.841600E-01 |
| Follicular-VS-Normal |
3.174600E-04 |
| Other-VS-Normal |
5.525600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.419000E-04 |
| Normal-vs-N1 |
1.188220E-02 |
| N0-vs-N1 |
7.900600E-01 |
|
|
